ScoreWhy is Boston Scientific Corp. ?
1
Healthy long term growth as Net Sales has grown by an annual rate of 12.73%
- OPERATING CASH FLOW(Y) Highest at USD 4,285 MM
- ROCE(HY) Highest at 11.71%
- NET SALES(Q) Highest at USD 5,061 MM
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Boston Scientific Corp. should be less than 10%
- Overall Portfolio exposure to Retailing should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Boston Scientific Corp. for you?
Low Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Boston Scientific Corp.
-55.32%
0.77
23.90%
S&P 500
25.41%
0.70
20.15%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
15.16%
EBIT Growth (5y)
46.76%
EBIT to Interest (avg)
5.69
Debt to EBITDA (avg)
2.84
Net Debt to Equity (avg)
0.47
Sales to Capital Employed (avg)
0.52
Tax Ratio
18.32%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
94.77%
ROCE (avg)
6.99%
ROE (avg)
7.79%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
36
Industry P/E
Price to Book Value
4.99
EV to EBIT
31.98
EV to EBITDA
23.94
EV to Capital Employed
3.88
EV to Sales
6.49
PEG Ratio
0.44
Dividend Yield
NA
ROCE (Latest)
12.12%
ROE (Latest)
13.88%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend17What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 4,341 MM
ROCE(HY)
Highest at 14.83%
RAW MATERIAL COST(Y)
Fallen by -2.86% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at 36.75 %
NET PROFIT(Q)
Highest at USD 1,304 MM
EPS(Q)
Highest at USD 0.9
-2What is not working for the Company
INTEREST(Q)
At USD 93 MM has Grown at 173.53%
Here's what is working for Boston Scientific Corp.
Operating Cash Flow
Highest at USD 4,341 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Profit
Highest at USD 1,304 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Net Profit
At USD 1,304 MM has Grown at 54.8%
over average net sales of the previous four periods of USD 842.37 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 0.9
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debt-Equity Ratio
Lowest at 36.75 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -2.86% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Boston Scientific Corp.
Interest
At USD 93 MM has Grown at 173.53%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
